4.5 Article

Early Predictors of Juvenile Sacroiliitis in Enthesitis-related Arthritis

Journal

JOURNAL OF RHEUMATOLOGY
Volume 37, Issue 11, Pages 2395-2401

Publisher

J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.100090

Keywords

JUVENILE IDIOPATHIC ARTHRITIS; ENTHESITIS-RELATED ARTHRITIS; SACROILIAC INVOLVEMENT; MAGNETIC RESONANCE IMAGING

Categories

Ask authors/readers for more resources

Objective. To identify early predictors of sacroiliac (SI) involvement in a cohort of patients with enthesitis-related arthritis (ERA). Methods. During a 7-year followup period, all consecutive patients fulfilling the ILAR classification criteria for ERA were enrolled. Data collected included demographic, clinical and laboratory variables at disease onset, at the onset of inflammatory back pain, and at the last available followup visit. Pelvis radiographs and dynamic magnetic resonance imaging (MRI) scans for SI joints were obtained simultaneously in all patients who developed inflammatory back pain. Results. Fifty-nine children with ERA were studied; 40 male, 19 female; median age at disease onset 9 years 4 months (range 6 yrs 6 mo - 13 yrs 3 mo). At a median interval after disease onset of 1 year 3 months, 21 children reported symptoms of inflammatory back pain. In all cases, radiographs of SI joints were negative, while dynamic MRI revealed acute sacroiliitis in 17 cases. Multivariate analysis showed that the early predictors of SI were the number of active joints (p < 0.03) and the number of active entheses (p < 0.001) at onset. Conclusion. In our cohort, roughly 30% of children with ERA/juvenile idiopathic arthritis develop clinical and MRI evidence of sacroiliitis, detectable with dynamic MRI as early as I year after disease onset. Additional data from larger case series are needed to assess the specificity and sensitivity of this technique in the early phase of the disease and to confirm the rate of SI involvement reported in this cohort. (First Release September 1 2010; J Rheumatol 2010;37:2395-401; doi:10.3899/jrheum.100090)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Anticoagulation and Thrombotic Events in the Multisystem Inflammatory Syndrome in Children: Experience of a Single-center Cohort and Review of the Literature

Francesco Pegoraro, Donatella Lasagni, Sandra Trapani, Maria V. Mastrolia, Gabriele Simonini, Giuseppe Indolfi, Massimo Resti

Summary: This retrospective study evaluated MIS-C patients admitted to a children's hospital in Italy and found that thromboembolic events are rare complications of MIS-C. Most patients received anticoagulation and prophylactic anticoagulation was associated with cardiac involvement and higher ferritin levels. This study provides insights into the relationship between MIS-C and thromboembolic events and suggests that established risk factors for pediatric thromboembolism may also apply to MIS-C patients.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2023)

Letter Oncology

Kikuchi-Fujimoto disease complicated with hemophagocytic lymphohistiocytosis

Antonio Scarcella, Edoardo Marrani, Maria Luisa Coniglio, Gabriele Simonini, Elena Sieni

PEDIATRIC BLOOD & CANCER (2023)

Article Rheumatology

Baricitinib for juvenile idiopathic arthritis: a monocentric case series

Ilaria Maccora, Teodoro Oliverio, Ilaria Pagnini, Edoardo Marrani, Maria Vincenza Mastrolia, Gabriele Simonini

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Immunology

Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients

Anna Vanni, Alessio Mazzoni, Roberto Semeraro, Manuela Capone, Patrick Maschmeyer, Giulia Lamacchia, Lorenzo Salvati, Alberto Carnasciali, Parham Farahvachi, Teresa Giani, Gabriele Simonini, Giovanni Filocamo, Micol Romano, Francesco Liotta, Mir-Farzin Mashreghi, Lorenzo Cosmi, Rolando Cimaz, Alberto Magi, Laura Maggi, Francesco Annunziato

Summary: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic condition in childhood, with T cells playing a key role in its pathogenesis. The expression of PD-1 on CD4+ and CD8+ T cells in JIA indicates their active contribution in sustaining chronic inflammation. Targeting PD-1 could be an effective therapeutic strategy for JIA.

EUROPEAN JOURNAL OF IMMUNOLOGY (2023)

Review Immunology

Challenges and management of childhood noninfectious chronic uveitis

Ilaria Maccora, Edoardo Marrani, Ilaria Pagnini, Maria Vincenza Mastrolia, Cinzia de Libero, Roberto Caputo, Gabriele Simonini

Summary: Childhood uveitis is a serious condition that can lead to blindness if not properly recognized and treated. This review discusses the main causes, diagnostic approach, risk factors, and difficulties in eye examination for childhood uveitis. The treatment options for childhood uveitis are also discussed in terms of choice, timing, and withdrawal.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Editorial Material Immunology

Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis

Ilaria Maccora, Preston Land, Virginia Miraldi Utz, Sheila T. Angeles-Han

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Editorial Material Pediatrics

Splenomegaly in Kawasaki Disease: A Pitfall in Diagnosis

Francesca Miselli, Maria Vincenza Mastrolia, Gabriele Simonini, Sandra Trapani, Giovanni Battista Calabri

Summary: Among 365 children diagnosed with Kawasaki disease, only 5 (1.4%) had splenomegaly, with 2 of them complicated by macrophage activation syndrome and 3 ultimately diagnosed with alternative systemic illness. Splenomegaly is an atypical manifestation in Kawasaki disease and may indicate underlying complications such as macrophage activation syndrome or other diagnoses.

JOURNAL OF PEDIATRICS (2023)

Article Rheumatology

Tocilizumab in Behcet Disease: A Multicenter Study of 30 Patients

Mohamed-Yacine Khitri, Alessandra Bartoli, Georgina Maalouf, Alban Deroux, Carlo Salvarani, Giacomo Emmi, Omer Karadag, Gerard Espinosa, Mathilde Leclercq, Gabriele Simonini, Mathieu Vautier, Patrice Cacoub, David Saadoun

Summary: This study evaluated the efficacy of tocilizumab in patients with refractory Behcet disease. The results showed that 83% of patients responded to tocilizumab, with 60% achieving complete response and 23% achieving partial response. Tocilizumab also significantly reduced steroid dosage and the need for concomitant disease-modifying antirheumatic drugs. However, a small number of patients experienced mild to moderate side effects and serious adverse events.

JOURNAL OF RHEUMATOLOGY (2023)

Article Ophthalmology

Childhood Chronic Idiopathic Uveitis in a Multicentre International Cohort

Ilaria Maccora, Catherine Guly, Cinzia de Libero, Roberto Caputo, Athimalaipet Ramanan, Gabriele Simonini

Summary: This study reports the demographic, clinical characteristics, and outcomes of children with idiopathic non-infectious uveitis (iNIU) in a multicentric retrospective study. The results show that the majority of patients have a significant improvement in vision at 3 years, but 1 in 6 had impaired vision or blindness in their worse eye.

OCULAR IMMUNOLOGY AND INFLAMMATION (2023)

Review Genetics & Heredity

A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review

Ilaria Maccora, Valerio Maniscalco, Silvia Campani, Simona Carrera, Giulia Abbati, Edoardo Marrani, Maria Vincenza Mastrolia, Gabriele Simonini

Summary: Deficiency of adenosine deaminase 2 (DADA2) is a rare monogenic autoinflammatory disease with a highly variable phenotype. A systematic review identified 90 publications describing 378 patients with DADA2. The most common clinical characteristics included cutaneous manifestations, hematological manifestations, recurrent fever, stroke and polyneuropathy, immunological abnormalities, arthralgia/arthritis, splenomegaly, abdominal involvement, hepatomegaly, recurrent infections, myalgia, and kidney involvement. Early diagnosis and treatment are crucial due to the significant morbidity and mortality associated with this disease.

ORPHANET JOURNAL OF RARE DISEASES (2023)

Article Medicine, General & Internal

Concomitant Use of Elexacaftor/Tezacaftor/Ivacaftor and Etanercept in a Cystic Fibrosis Patient with Juvenile Idiopathic Arthritis

Sara Immacolata Orsini, Edoardo Marrani, Ilaria Pagnini, Giovanni Taccetti, Vito Terlizzi, Gabriele Simonini

Summary: Patients with cystic fibrosis can also have juvenile idiopathic arthritis, and this report describes the first pediatric case of a patient with cystic fibrosis, Basedow's disease, and juvenile idiopathic arthritis who received treatment with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) and anti-tumor necrosis factor alpha (anti-TNF alpha). The report suggests that this combination treatment is safe and effective for these patients.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Laser Flare Photometry to Monitor Childhood Chronic Uveitis: A Preliminary Report of a Monocentric Italian Experience

Ilaria Maccora, Cinzia De Libero, Matilde Peri, Gioia Danti, Alessio Rossi, Edoardo Marrani, Roberta Pasqualetti, Ilaria Pagnini, Maria Vincenza Mastrolia, Gabriele Simonini

Summary: This study attempted to use laser flare photometry (LFP) in the clinical practice of childhood chronic non-infectious uveitis (cNIU). The results showed a good correlation between LFP measurements and slit lamp evaluation (SLE) results, and LFP values were positively correlated with the presence of complications. This suggests that LFP may be a reliable objective modality to monitor intraocular inflammation in children with cNIU.

DIAGNOSTICS (2023)

Letter Rheumatology

Efficacy of Janus kinase inhibitor baricitinib in the treatment of refractory juvenile dermatomyositis complicated by calcinosis

M. V. Mastrolia, S. I. Orsini, E. Marrani, I. Maccora, I. Pagnini, G. Simonini

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2023)

Article Pediatrics

CD38high/HLA-DR+ CD8+ T cells as potential biomarker of hemophagocytic lymphohistiocytosis secondary to visceral Leishmania infection

Maria Vincenza Mastrolia, Silvia Boscia, Luisa Galli, Lorenzo Lodi, Laura Pisano, Ilaria Maccora, Silvia Ricci, Ilaria Pagnini, Edoardo Marrani, Chiara Azzari, Gabriele Simonini

Summary: Leishmaniasis is linked to HLH, and the measurement of CD8(+) CD38(high)/HLA-DR+ T cells is crucial in distinguishing HLH from sepsis or healthy individuals in children presenting with shock and organ failure.

EUROPEAN JOURNAL OF PEDIATRICS (2023)

No Data Available